2018年《实用肝脏病杂志》精彩回顾

doi:10.3969/j.issn.1672-5069.2019.01.001

Abstract

Fan Jiangao.. Highlights of Journal of Practical Hepatology in 2018[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 1-3.

[1] 严晨丽,王晶晶,王军.非酒精性脂肪性肝病合并冠心病患者冠脉病变程度及其危险因素分析.实用肝脏病杂志,2018,21(5):737-740.
[2] 关阳,陈金军,邓红. 非酒精性脂肪性肝病患者人体脂肪成分指标的变化. 实用肝脏病杂志,2018,21(2):229-232.
[3] 黄娇凤,林苏,王明芳,等. 恩替卡韦治疗慢性乙型肝炎合并非酒精性脂肪性肝病患者疗效及其对肝组织脂肪变的影响.实用肝脏病杂志,2018,21(6):863-867.
[4] 汪佩文,董育玮,李郑红,等.94例不明原因肝功能异常患者临床与肝组织病理学分析.实用肝脏病杂志,2018,21(2):225-228.
[5] 王新钊,马丽娟,段心科,等. 慢性乙型肝炎患者情绪和应对方式对生活质量的影响. 实用肝脏病杂志,2018,21(4):569-572.
[6] 郑珍川,许夕海.慢性乙型肝炎患者临床和肝组织病理学特点及影响肝纤维化因素分析.实用肝脏病杂志,2018,21(5):713-716.
[7] 赵明英,李春林.血清HBsAg低水平患者肝组织炎症活动和纤维化程度及其相关影响因素分析.实用肝脏病杂志,2018,21(5):725-728.
[8] 黄春明,杨湛,聂玉强,等.γ-谷氨酰转肽酶/血小板比值对血清转氨酶正常的慢性HBV感染者肝纤维化的预测价值分析.实用肝脏病杂志,2018,21(6):859-862.
[9] 王芳芳,张国范,郭春霞,等.长期口服恩替卡韦治疗的慢性乙型肝炎患者换用α干扰素治疗临床疗效随访研究.实用肝脏病杂志,2018,21(5):721-724.
[10] 史罗明,周根法,孙冬林.聚乙二醇干扰素-α-2a治疗血清低水平HBsAg阳性的慢性乙型肝炎患者临床结局预测研究.实用肝脏病杂志,2018,21(4):565-568.
[11] 陈欣,陈立冬,李庭红. 替诺福韦酯治疗多重耐药的乙型肝炎肝硬化患者疗效初步研究. 实用肝脏病杂志,2018,21(5):681-684.
[12] 章燕虹,李游,陈龙,沈薇. 2890例住院的肝硬化患者病因和并发症分析. 实用肝脏病杂志,2018,21(3):344-347.
[13] 任涛,潘雯,许立,等. 藏族肝硬化患者临床特征分析.实用肝脏病杂志,2018,21(3):352-355.
[14] 余珊珊,孙露,韩东刚,等. 超声三维斑点追踪技术检查肝硬化患者左心室收缩功能初步研究.实用肝脏病杂志,2018,21(2):245-248.
[15] 简佑容,陈世耀. 肝硬化门脉高压症患者心脏功能影响因素及其状况评价. 实用肝脏病杂志,2018,21(3):336-339.
[16] 邱婷,金燕,吕颐菲,等. 肝硬化并发门静脉血栓危险因素的Logistic回归分析. 实用肝脏病杂志,2018,21(5):916-919.
[17] 吴文豪,符汉光,陈朝琴. 肝硬化并发自发性细菌性腹膜炎患者临床特点、病原学和药敏结果分析.实用肝脏病杂志,2018,21(3):356-359.
[18] 张骏飞,宋海燕,陈曦,等. 多次人脐带间充质干细胞移植治疗失代偿期乙型肝炎肝硬化患者临床研究.实用肝脏病杂志,2018,21(5):693-696.
[19] 吴凤萍,李亚萍,杨颖,等. 血糖和总胆固醇水平对肝衰竭患者预后的影响. 实用肝脏病杂志,2018,21(3):413-416.
[20] 李磊,胡辉,郑晓玮,等. 四种基于MELD的评分系统对慢加急性乙型肝炎肝衰竭患者短期生存的预测价值分析.实用肝脏病杂志,2018,21(3):417-420.
[21] 于旭彤,蒋秀华,祁婷婷,等. 前瞻性研究圆四种出血事件评估标准评估慢加急性肝衰竭患者出血事件.实用肝脏病杂志,2018,21(6):885-889.
[22] 郑婷婷,蒋珊珊,方钟燎,陈茂伟. 慢性乙型肝炎、肝硬化和肝衰竭患者肠道菌群变化研究. 实用肝脏病杂志,2018,21(6):899-902.
[23] 马茜,张帅,苗红,等. 钆塞酸二钠增强MRI与增强CT诊断肝脏局灶性病变效能对比研究. 实用肝脏病杂志,2018,21(6):951-958.
[24] 刘欣,张莹,张文耀,汪秀玲.多排螺旋CT与MRI增强扫描原发性肝癌病灶影像学表现和诊断效能分析.实用肝脏病杂志,2018,21(4):513-516.
[25] 鲁雪红,张源,刘文亚. 多排螺旋CT三期增强与3.0T MR多期动态增强扫描诊断肝细胞癌的价值分析.实用肝脏病杂志,2018,21(5):749-752.
[26] 张财源,李金凝,刘欢欢,汪登斌. PRETEXT分期系统对儿童肝母细胞瘤病理学分型和疗效评估的价值分析. 实用肝脏病杂志,2018,21(4):505-508.
[27] 安宝燕,王云,项晓刚,等. 乙型肝炎相关肝细胞癌患者预后的多因素分析. 实用肝脏病杂志,2018,21(5):924-927.
[28] 许建,张浩,俞小炯. 乙型肝炎相关性孤立性大肝癌手术切除患者长期疗效及影响预后因素分析. 实用肝脏病杂志,2018,21(3):426-430.
[29] 占国清,谭华炳,李芳,等.恩替卡韦抗病毒对TACE治疗的HBV DNA阴性乙型肝炎相关性肝癌的影响.实用肝脏病杂志,2018,21(1):96-99.
[30] 石朋,王坤,沈俊春,卢文波. CT检查在原发性肝癌患者经肝动脉化疗栓塞术后疗效评估中的应用价值分析.实用肝脏病杂志,2018,21(2):253-256.

Highlights of Journal of Practical Hepatology in 2018

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
[4]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[5]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[6]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[7]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[8]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[9]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[10]	Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
[11]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[12]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[13]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[14]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[15]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.